Novel prolyl endopeptidase inhibitor from <i>Myricaria germanica</i> alleviates steatohepatitis. [PDF]
Ullah K +8 more
europepmc +1 more source
Correction for Sakuma et al., Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis. [PDF]
europepmc +1 more source
Soluble Triggering Receptor Expressed on Myeloid Cells 2 is a Biomarker but Not a Mediator of Fibrosing Steatohepatitis. [PDF]
Dempsey JL +7 more
europepmc +1 more source
Burden and trends of NASH-related liver cancer associated with high fasting plasma glucose in China and globally from 1990 to 2021: a population-based analysis of the global burden of disease study. [PDF]
Yao Y, Ji C, Zhou C, Gui M.
europepmc +1 more source
Metabolic surgery in metabolic dysfunction-associated steatohepatitis: emerging evidence and clinical promise. [PDF]
Fukushima M, Miuma S, Miyaaki H.
europepmc +1 more source
Caffeine Ameliorates Metabolic-Associated Steatohepatitis by Rescuing Hepatic Dusp9
Xin Xin +8 more
openalex +1 more source
Prevalence and characteristics of metabolic dysfunction-associated steatohepatitis among pediatric patients in the MarketScan Databases. [PDF]
Peter-Marske KM +6 more
europepmc +1 more source

